TY - JOUR
T1 - Lymphoid disorders associated with HHV-8/KSHV infection
T2 - Facts and contentions
AU - Gaidano, G.
AU - Castaños-Velez, E.
AU - Biberfeld, P.
N1 - Funding Information:
The authors P Biberfeld and E Castafios-Velez, are supported by the Swedish Cancer Society, the Swedish Medical Research Council, the Cancer Society in Stockholm, the Karolinska Institute's Research Foundation, Stockholm, Sweden, and G Gaidano by ISS: Programma nazionale di ricerca sull'AIDS 1997 - Progetto Patologia clinica e terapia dell'AIDS, Rome, Italy, and Fondazione CRT, Torino, Italy. The authors' laboratories are part of the BIOMED-2 Concerted Action 'Pathogenesis of AIDS-KS' (contract no: BMH4-CT-2302).
PY - 1999/4
Y1 - 1999/4
N2 - Following the demonstration in 1994, that Kaposi's sarcoma (KS) was associated with a novel virus (KSHV or HHV-8) belonging to the lymphotropic herpes family, this virus was also found in certain lymphoid neoplasias of immunodeficient (HIV+) and immune competent hosts. The association of HHV- 8/KSHV infection is now well established with primary effusion lymphoma (PEL) or body cavity based lymphoma (BCBL) and multicentric Castleman's disease (MCD) of the plasma cell type. A possible pathogenic role of HHV-8/KSHV in other lymphoid tumours including primary central nervous system lymphoma (PCNSL) and multiple myeloma (MM) as well as some atypical lymphoproliferations and sarcoidosis has also been suggested, but this is at present a controversial matter, or not confirmed. Several HHV-8/KSHV genes, including potential oncogenes, genes homologous to various cellular genes and growth factors have been incriminated in the pathogenesis of KS and PEL/BCBL, but a common pathogenic mechanism for the clearly diverse proliferations represented by PEL, MCD and KS is at present not evident.
AB - Following the demonstration in 1994, that Kaposi's sarcoma (KS) was associated with a novel virus (KSHV or HHV-8) belonging to the lymphotropic herpes family, this virus was also found in certain lymphoid neoplasias of immunodeficient (HIV+) and immune competent hosts. The association of HHV- 8/KSHV infection is now well established with primary effusion lymphoma (PEL) or body cavity based lymphoma (BCBL) and multicentric Castleman's disease (MCD) of the plasma cell type. A possible pathogenic role of HHV-8/KSHV in other lymphoid tumours including primary central nervous system lymphoma (PCNSL) and multiple myeloma (MM) as well as some atypical lymphoproliferations and sarcoidosis has also been suggested, but this is at present a controversial matter, or not confirmed. Several HHV-8/KSHV genes, including potential oncogenes, genes homologous to various cellular genes and growth factors have been incriminated in the pathogenesis of KS and PEL/BCBL, but a common pathogenic mechanism for the clearly diverse proliferations represented by PEL, MCD and KS is at present not evident.
KW - AIDS related lymphoma
KW - Angio-follicular lymphoid hyperplasia/multicentric Castleman's disease
KW - Human herpes virus-8/Kaposi's sarcoma herpes virus
KW - Multiple myeloma
KW - Primary effusion lymphoma/body cavity based lymphoma
UR - http://www.scopus.com/inward/record.url?scp=0033005762&partnerID=8YFLogxK
U2 - 10.1007/bf02787352
DO - 10.1007/bf02787352
M3 - Article
SN - 0736-0118
VL - 16
SP - 8
EP - 12
JO - Medical Oncology
JF - Medical Oncology
IS - 1
ER -